Difficulty: Medium
Average Score: 90%
Practice
Select the drug which tends to reverse insulin resistance by increasing cellular glucose transporters.
Correct answer
B
Rationale
In the context of diabetic drugs, the correct answer to the question is B) Troglitazone. Troglitazone belongs to a class of drugs known as thiazolidinediones (TZDs) or glitazones. These drugs work by activating peroxisome proliferator-activated receptor gamma (PPAR-gamma), a nuclear receptor that regulates gene expression involved in glucose and lipid metabolism. By activating PPAR-gamma, troglitazone increases the expression of glucose transporter proteins, particularly GLUT4, which enhances cellular glucose uptake. This mechanism helps to reverse insulin resistance by improving the cell's ability to take up glucose, thereby lowering blood sugar levels.
Now let's examine why the other options are incorrect:
A) Glibenclamide: Glibenclamide is a sulfonylurea drug that works by stimulating insulin release from pancreatic beta cells. It does not reverse insulin resistance by increasing cellular glucose transporters.
C) Acarbose: Acarbose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the small intestine, thereby reducing postprandial blood glucose spikes. It does not directly increase cellular glucose transporters to reverse insulin resistance.
D) Prednisolone: Prednisolone is a corticosteroid that is used to reduce inflammation and suppress the immune system. It does not target insulin resistance or increase cellular glucose transporters.
Educational context:
Understanding the mechanism of action of different classes of diabetic drugs is crucial for healthcare professionals involved in the management of diabetes. Knowing how each drug works helps in making informed decisions about treatment options based on the underlying pathophysiology of the patient's condition. In the case of insulin resistance, drugs like troglitazone that target cellular glucose transporters play a significant role in improving insulin sensitivity and glycemic control.
Now let's examine why the other options are incorrect:
A) Glibenclamide: Glibenclamide is a sulfonylurea drug that works by stimulating insulin release from pancreatic beta cells. It does not reverse insulin resistance by increasing cellular glucose transporters.
C) Acarbose: Acarbose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the small intestine, thereby reducing postprandial blood glucose spikes. It does not directly increase cellular glucose transporters to reverse insulin resistance.
D) Prednisolone: Prednisolone is a corticosteroid that is used to reduce inflammation and suppress the immune system. It does not target insulin resistance or increase cellular glucose transporters.
Educational context:
Understanding the mechanism of action of different classes of diabetic drugs is crucial for healthcare professionals involved in the management of diabetes. Knowing how each drug works helps in making informed decisions about treatment options based on the underlying pathophysiology of the patient's condition. In the case of insulin resistance, drugs like troglitazone that target cellular glucose transporters play a significant role in improving insulin sensitivity and glycemic control.